Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals
Clinical Gastroenterology and Hepatology · 2024-01 · 22 (1) · 91-101.e6
DOI: 10.1016/j.cgh.2023.05.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-01. Verfasst von Jagpreet Chhatwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Dana Farber/Harvard Cancer Center…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Dana Farber/Harvard Cancer Center, Boston, Massachusetts; Liver Center and Gastrointestinal Division, M…
- Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Prince Mohammed Bin Salman College of Business & Entrepreneurship, King Abdullah Economic City, Saudi A…
- Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
- Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Brandeis International Business School, Brandeis University, Boston, Massachusetts.
- Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
- Department of Medicine, Baylor College of Medicine, Houston, Texas; Houston Veterans Affairs Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Te…
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- US Department of Defense
- American Cancer Society
- National Cancer Institute
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Chhatwal, J., Hajjar, A., Mueller, P. P., Nemutlu, G., Kulkarni, N., Peters, M. L. B., & Kanwal, F. (2024). Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals. Clinical Gastroenterology and Hepatology, 22(1), 91-101.e6. https://doi.org/10.1016/j.cgh.2023.05.024
Vancouver
Chhatwal J, Hajjar A, Mueller PP, Nemutlu G, Kulkarni N, Peters MLB, et al. Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals. Clinical Gastroenterology and Hepatology. 2024;22(1):91-101.e6. doi:10.1016/j.cgh.2023.05.024
BibTeX
@article{Chhatwal2024,
author = {Chhatwal, Jagpreet and Hajjar, Ali and Mueller, Peter P and Nemutlu, Gizem and Kulkarni, Neeti and Peters, Mary Linton B and Kanwal, Fasiha},
title = {Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
volume = {22},
number = {1},
pages = {91--101.e6},
doi = {10.1016/j.cgh.2023.05.024}
}
EUVIMED